ZIOPHARM ONCOLOGY INC Insider Trading for January 2016
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ZIOPHARM ONCOLOGY INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in ZIOPHARM ONCOLOGY INC for January 2016.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 05 2016 | ZIOP | ZIOPHARM ONCOLOGY ... | Cooper Laurence James Neil | Chief Executive Off ... | Grant | A | 0.00 | 131,000 | 0 | 1,131,000 | 1000 K to 1.1 M (+13.10 %) |
| Jan 05 2016 | ZIOP | ZIOPHARM ONCOLOGY ... | LEBEL FRANCOIS | Executive Vice Pres ... | Grant | A | 0.00 | 65,000 | 0 | 65,000 | 0 to 65 K |
| Jan 05 2016 | ZIOP | ZIOPHARM ONCOLOGY ... | Tarriff Scott | Director | Option Exercise | A | 8.31 | 40,000 | 332,400 | 40,000 | |
| Jan 05 2016 | ZIOP | ZIOPHARM ONCOLOGY ... | CANNON JAMES ANTHONY | Director | Grant | A | 0.00 | 26,661 | 0 | 326,963 | 300.3 K to 327 K (+8.88 %) |
| Jan 05 2016 | ZIOP | ZIOPHARM ONCOLOGY ... | CANNON JAMES ANTHONY | Director | Payment of Exercise | F | 8.31 | 4,177 | 34,711 | 300,302 | 304.5 K to 300.3 K (-1.37 %) |
| Jan 05 2016 | ZIOP | ZIOPHARM ONCOLOGY ... | CANNON JAMES ANTHONY | Director | Payment of Exercise | F | 8.31 | 1,462 | 12,149 | 304,479 | 305.9 K to 304.5 K (-0.48 %) |
| Jan 05 2016 | ZIOP | ZIOPHARM ONCOLOGY ... | BELBEL CAESAR J | COO, CLO, and Secre ... | Grant | A | 0.00 | 65,000 | 0 | 124,201 | 59.2 K to 124.2 K (+109.80 %) |
| Jan 05 2016 | ZIOP | ZIOPHARM ONCOLOGY ... | Lafond Kevin G | Vice Pres., Treasur ... | Grant | A | 0.00 | 28,000 | 0 | 28,000 | 0 to 28 K |
| Jan 05 2016 | ZIOP | ZIOPHARM ONCOLOGY ... | BRENNAN MURRAY | Director | Grant | A | 0.00 | 26,661 | 0 | 39,161 | 12.5 K to 39.2 K (+213.29 %) |
| Jan 05 2016 | ZIOP | ZIOPHARM ONCOLOGY ... | Fowler Wyche | Director | Grant | A | 0.00 | 26,661 | 0 | 131,004 | 104.3 K to 131 K (+25.55 %) |
| Jan 05 2016 | ZIOP | ZIOPHARM ONCOLOGY ... | Fowler Wyche | Director | Payment of Exercise | F | 8.31 | 6,683 | 55,536 | 104,343 | 111 K to 104.3 K (-6.02 %) |
| Jan 05 2016 | ZIOP | ZIOPHARM ONCOLOGY ... | Fowler Wyche | Director | Payment of Exercise | F | 8.31 | 2,340 | 19,445 | 111,026 | 113.4 K to 111 K (-2.06 %) |
| Jan 05 2016 | ZIOP | ZIOPHARM ONCOLOGY ... | WEISER MICHAEL | Director | Grant | A | 0.00 | 26,661 | 0 | 191,548 | 164.9 K to 191.5 K (+16.17 %) |
| Jan 05 2016 | ZIOP | ZIOPHARM ONCOLOGY ... | WEISER MICHAEL | Director | Payment of Exercise | F | 8.31 | 2,047 | 17,011 | 164,887 | 166.9 K to 164.9 K (-1.23 %) |
| Jan 04 2016 | ZIOP | ZIOPHARM ONCOLOGY ... | KIRK RANDAL J | Director | Grant | A | 0.00 | 26,661 | 0 | 122,309 | 95.6 K to 122.3 K (+27.87 %) |